(Q43582604)

24 November 2017

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia (English)

1 reference

24 November 2017

0 references

0 references

1 reference

1 reference

Miller DD

1

1 reference

24 November 2017

Andreasen NC

2

1 reference

24 November 2017

O'Leary DS

3

1 reference

24 November 2017

Watkins GL

4

1 reference

24 November 2017

Boles Ponto LL

5

1 reference

24 November 2017

Hichwa RD

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

Biological Psychiatry

1 reference

24 November 2017

49

1 reference

24 November 2017

8

1 reference

24 November 2017

704-715

1 reference

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Negative symptoms in schizophrenia. Definition and reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Voxel processing techniques for the antemortem study of neuroanatomy and neuropathology using magnetic resonance imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Remembering the past: two facets of episodic memory explored with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Tests for comparing images based on randomization and permutation methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Patterns of metabolic activity in the treatment of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Positron emission tomography in schizophrenic patients with and without neuroleptic medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

A simplified in vivo autoradiographic strategy for the determination of regional cerebral blood flow by positron emission tomography: theoretical considerations and validation studies in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Activation of specific cortical regions by apomorphine: an [15O]H2O PET study in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Serotonin-dopamine interaction and its relevance to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Changes in caudate volume with neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Retrospective geometric correlation of MR, CT, and PET images.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Risperidone in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Alogia, attentional impairment, and inappropriate affect: their status in the dimensions of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Accurate three-dimensional registration of CT, PET, and/or MR images of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

A functional neuroanatomy of hallucinations in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Dysfunctional cortico-cerebellar circuits cause 'cognitive dysmetria' in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

Rapid Automated Algorithm for Aligning and Reslicing PET Images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

A three-dimensional statistical analysis for CBF activation studies in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901001-5

10.1016/S0006-3223(00)01001-5

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference